BR9803232A - Vaicna de neospora. - Google Patents
Vaicna de neospora.Info
- Publication number
- BR9803232A BR9803232A BR9803232-1A BR9803232A BR9803232A BR 9803232 A BR9803232 A BR 9803232A BR 9803232 A BR9803232 A BR 9803232A BR 9803232 A BR9803232 A BR 9803232A
- Authority
- BR
- Brazil
- Prior art keywords
- neospora
- vaicna
- prepared
- abortion
- clinics
- Prior art date
Links
- 241001147660 Neospora Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010000210 abortion Diseases 0.000 abstract 1
- 231100000176 abortion Toxicity 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Patente de Invenção: <B>"VACINA DE NEOSPORA"<D>. A presente invenção fornece um homogenato preparado a partir de células de Neospora, e vacinas contra a neosporose preparadas a partir dele, as quais são úteis na prevenção de doenças, clínicas e abortamento em mamíferos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5695697P | 1997-08-26 | 1997-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9803232A true BR9803232A (pt) | 2000-01-11 |
Family
ID=22007613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9803232-1A BR9803232A (pt) | 1997-08-26 | 1998-04-25 | Vaicna de neospora. |
Country Status (16)
Country | Link |
---|---|
US (2) | US6787146B2 (pt) |
EP (2) | EP1477184A3 (pt) |
JP (1) | JP3049016B2 (pt) |
CN (1) | CN1211449A (pt) |
AR (1) | AR016396A1 (pt) |
AT (1) | ATE277631T1 (pt) |
AU (1) | AU764455B2 (pt) |
BR (1) | BR9803232A (pt) |
CA (1) | CA2245425C (pt) |
DE (1) | DE69826593T2 (pt) |
DK (1) | DK0898969T3 (pt) |
ES (1) | ES2227783T3 (pt) |
NZ (1) | NZ331529A (pt) |
PT (1) | PT898969E (pt) |
TW (2) | TWI228419B (pt) |
ZA (1) | ZA987662B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1032416B1 (en) * | 1997-10-20 | 2007-01-24 | Bayer Corporation | Neospora vaccines |
EP0953641A3 (en) * | 1998-03-26 | 2002-03-13 | Pfizer Products Inc. | Polynucleotide molecules encoding neospora proteins |
CA2496750C (en) * | 2002-08-26 | 2014-10-21 | Pfizer Products Inc. | Vaccine for respiratory and reproductive system infections in cattle |
EP1578459A3 (en) * | 2002-10-25 | 2005-11-23 | University of Connecticut Health Center | Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
US20050164168A1 (en) * | 2003-03-28 | 2005-07-28 | Cullum Malford E. | Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines |
ES2319242B1 (es) | 2005-12-23 | 2009-12-01 | Laboratorios Hipra, S.A. | Aislado avirulento de neospora canimum y sus usos. |
ES2326770B1 (es) | 2007-07-13 | 2010-07-26 | Universidad Complutense De Madrid | Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora. |
CN101831495B (zh) * | 2010-04-30 | 2013-06-19 | 新疆出入境检验检疫局检验检疫技术中心 | 一种牛新孢子虫病的检测方法及应用 |
EP2708237A1 (en) * | 2012-09-17 | 2014-03-19 | Université de Droit et de la Santé de Lille 2 | Pharmaceutical composition for its use in the preventive treatment of infections caused by an intracellular pathogen, more particularly Toxoplasma gondii |
EP2994162B1 (en) | 2013-05-08 | 2021-04-07 | Pharmgate Biologics Inc. | Vaccine for pcv2 and mycoplasma |
EP3368070B9 (en) | 2015-10-28 | 2023-10-18 | Universidad Complutense De Madrid | Neospora vaccine composition |
EP3522871B1 (en) | 2016-10-05 | 2021-11-17 | Zoetis Services LLC | Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643718A (en) * | 1993-11-04 | 1997-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | Transfection and genetic manipulations in obligate intracellular parasites |
US5707617A (en) * | 1994-03-21 | 1998-01-13 | The Regents Of The University Of California | Bovine neospora isolates |
US5889166A (en) * | 1996-05-10 | 1999-03-30 | The Regents Of The University Of California | Recombinant neospora antigens and their uses |
US6743430B1 (en) | 1995-03-29 | 2004-06-01 | Richard E. Parizek | Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose |
CA2184132C (en) | 1995-09-21 | 2011-03-15 | Kristina J. Hennessy | An adjuvanted vaccine which is substantially free of non-host albumin |
WO1997017082A1 (en) | 1995-11-09 | 1997-05-15 | Trustees Of Dartmouth College | A vaccine against toxoplasma gondii |
DE69729839T2 (de) * | 1996-11-12 | 2005-07-21 | Pfizer Inc. | Attenuierter lebender Neospora Impfstoff |
-
1998
- 1998-04-25 BR BR9803232-1A patent/BR9803232A/pt not_active Application Discontinuation
- 1998-08-12 EP EP04019906A patent/EP1477184A3/en not_active Withdrawn
- 1998-08-12 EP EP98306431A patent/EP0898969B1/en not_active Revoked
- 1998-08-12 AT AT98306431T patent/ATE277631T1/de not_active IP Right Cessation
- 1998-08-12 DE DE69826593T patent/DE69826593T2/de not_active Expired - Fee Related
- 1998-08-12 ES ES98306431T patent/ES2227783T3/es not_active Expired - Lifetime
- 1998-08-12 PT PT98306431T patent/PT898969E/pt unknown
- 1998-08-12 DK DK98306431T patent/DK0898969T3/da active
- 1998-08-24 AR ARP980104191A patent/AR016396A1/es unknown
- 1998-08-24 CA CA002245425A patent/CA2245425C/en not_active Expired - Fee Related
- 1998-08-25 AU AU81884/98A patent/AU764455B2/en not_active Ceased
- 1998-08-25 TW TW087114005A patent/TWI228419B/zh not_active IP Right Cessation
- 1998-08-25 CN CN98117976A patent/CN1211449A/zh active Pending
- 1998-08-25 NZ NZ331529A patent/NZ331529A/en unknown
- 1998-08-25 TW TW092112372A patent/TW200305433A/zh unknown
- 1998-08-25 ZA ZA9807662A patent/ZA987662B/xx unknown
- 1998-08-26 JP JP10240174A patent/JP3049016B2/ja not_active Expired - Lifetime
-
2001
- 2001-11-09 US US10/036,351 patent/US6787146B2/en not_active Expired - Fee Related
-
2004
- 2004-06-21 US US10/872,949 patent/US20040223982A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2245425A1 (en) | 1999-02-26 |
DE69826593D1 (de) | 2004-11-04 |
AU8188498A (en) | 1999-03-11 |
CA2245425C (en) | 2006-12-12 |
JP3049016B2 (ja) | 2000-06-05 |
PT898969E (pt) | 2005-01-31 |
EP1477184A3 (en) | 2006-04-12 |
EP1477184A2 (en) | 2004-11-17 |
EP0898969B1 (en) | 2004-09-29 |
ZA987662B (en) | 2000-02-25 |
AU764455B2 (en) | 2003-08-21 |
US6787146B2 (en) | 2004-09-07 |
AR016396A1 (es) | 2001-07-04 |
US20020058046A1 (en) | 2002-05-16 |
ES2227783T3 (es) | 2005-04-01 |
TWI228419B (en) | 2005-03-01 |
DE69826593T2 (de) | 2005-02-10 |
CN1211449A (zh) | 1999-03-24 |
EP0898969A3 (en) | 2001-02-07 |
US20040223982A1 (en) | 2004-11-11 |
DK0898969T3 (da) | 2005-01-17 |
JPH11130683A (ja) | 1999-05-18 |
EP0898969A2 (en) | 1999-03-03 |
ATE277631T1 (de) | 2004-10-15 |
TW200305433A (en) | 2003-11-01 |
NZ331529A (en) | 1999-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69805527T2 (de) | Hochverformbare, korrosionsbeständige al-legierung | |
IT1302347B1 (it) | Procedimento per la produzione diretta di perossido di idrogeno. | |
IS5619A (is) | (4-Arýlsúlfónýlamínó) -tetrahýdrópýran-4-karboxýlsýru hýdroxamíð | |
FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
BR9803232A (pt) | Vaicna de neospora. | |
FR2794019B1 (fr) | Implant d'osteosynthese | |
ATE392214T1 (de) | Impfstoff gegen geschlechtlich übertragene krankheiten | |
IT1303472B1 (it) | Scarpetta particolarmente adatta per arrampicata libera. | |
BR0012553A (pt) | Pastilhas contendo ambroxol | |
BR9910451A (pt) | Composto de policarbonato revestido e um polìmero | |
AU2002232419A1 (en) | Clinician's assistant system | |
ITGE980021A0 (it) | Corpetto equilibratore attrezzato. | |
PT1033988E (pt) | Formulacoes parentericas compreendendo 10-hidroxi-10,11-tetra-hidrocarbamazepina agua e glucose | |
BR8103051Y1 (pt) | bicicleta infantil. | |
IT1298849B1 (it) | Utensile per l'imbutitura di parti di lamiera sagomate. | |
BR0012547A (pt) | ésteres oligomerécos de ácido bisclorocarbÈnico obtidos de bisfenóis cicloalifáticos selecionados e outros bisfenóis | |
AU2003276009A1 (en) | Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c | |
NO20021856L (no) | Koplingsdal | |
WO2000032626A8 (en) | Methods of using epitope peptides of human pathogens | |
GB9704977D0 (en) | FIV vaccine | |
BR9805251A (pt) | Veículo. | |
IT1320401B1 (it) | Procedimento per la fabbricazione di componenti di un'ossatura ecomponenti di ossatura. | |
Holsinger | Voice of the Living Light: Hildegard of Bingen and Her World | |
ITMI992457A0 (it) | Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide | |
SE0100533D0 (sv) | Informatonssystem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |